Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Menu

Black Diamond Therapeutics Inc (BDTX)

Black Diamond Therapeutics Inc (BDTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Black Diamond Therapeutics Reports First Quarter 2025 Financial Results and Provides Corporate Update GlobeNewswire - Mon May 12, 3:05PM CDT

BDTX : 2.17 (+2.84%)
Black Diamond Therapeutics to Participate in Upcoming Investor Conferences GlobeNewswire - Mon Mar 31, 7:00AM CDT

BDTX : 2.17 (+2.84%)
Black Diamond Therapeutics Shares Jump On New Partnership With France-Based Servier: Retail Sentiment Hits Year-High Stocktwits - Wed Mar 19, 1:28PM CDT

As part of the deal, Servier will develop and commercialize the clinical-stage oncology company’s BDTX-4933, a molecule designed to address solid tumors, including non-small cell lung cancer.

BDTX : 2.17 (+2.84%)
VTI : 291.85 (-0.33%)
IWM : 209.08 (+0.05%)
Servier and Black Diamond Therapeutics Announce Global Licensing Agreement for BDTX-4933, A Targeted Oncology Therapy GlobeNewswire - Wed Mar 19, 6:00AM CDT

BDTX : 2.17 (+2.84%)
Black Diamond: Q4 Earnings Snapshot AP - Thu Mar 6, 3:09PM CST

Black Diamond: Q4 Earnings Snapshot

BDTX : 2.17 (+2.84%)
Black Diamond Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update GlobeNewswire - Thu Mar 6, 3:01PM CST

BDTX : 2.17 (+2.84%)
Black Diamond: Q3 Earnings Snapshot AP - Tue Nov 5, 2024

Black Diamond: Q3 Earnings Snapshot

BDTX : 2.17 (+2.84%)
Black Diamond Therapeutics Reports Third Quarter 2024 Financial Results and Provides Corporate Update GlobeNewswire - Tue Nov 5, 2024

BDTX : 2.17 (+2.84%)
Black Diamond Therapeutics to Participate in Upcoming Investor Conferences GlobeNewswire - Fri Nov 1, 2024

BDTX : 2.17 (+2.84%)
Black Diamond Therapeutics Announces Restructuring Plan to Focus Resources on BDTX-1535 and Extend Cash Runway GlobeNewswire - Mon Oct 7, 2024

BDTX : 2.17 (+2.84%)

Barchart Exclusives

Should You Buy This Dividend-Paying Silver Stock Now? Barchart - Tue May 20, 6:30PM CDT
With silver prices surging to multi-year highs, Pan American Silver’s recent acquisition and strong financials make it a compelling buy for investors seeking both growth and regular dividend income. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot